Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trial. (Q53787704)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trial. |
scientific article |
Statements
Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trial. (English)
D Poehlau
J Federlein
T Postert
M Sailer
F Bethke
L Kappos
J Haas
H Przuntek
1 April 1997
3
2
149-152
1 reference
1 reference
1 reference
1 reference